Cargando…

The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis

NR3C1, the gene encoding the glucocorticoid receptor, is polymorphic presenting numerous single nucleotide polymorphisms (SNPs) some of which are emerging as leading cause in the variability of manifestation and/or response to glucocorticoids in human diseases. Since 60–80% of patients with Diamond...

Descripción completa

Detalles Bibliográficos
Autores principales: Lonetti, Annalisa, Indio, Valentina, Dianzani, Irma, Ramenghi, Ugo, Da Costa, Lydie, Pospíšilová, Dagmar, Migliaccio, Anna Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549833/
https://www.ncbi.nlm.nih.gov/pubmed/34721069
http://dx.doi.org/10.3389/fphys.2021.745032
_version_ 1784590847813091328
author Lonetti, Annalisa
Indio, Valentina
Dianzani, Irma
Ramenghi, Ugo
Da Costa, Lydie
Pospíšilová, Dagmar
Migliaccio, Anna Rita
author_facet Lonetti, Annalisa
Indio, Valentina
Dianzani, Irma
Ramenghi, Ugo
Da Costa, Lydie
Pospíšilová, Dagmar
Migliaccio, Anna Rita
author_sort Lonetti, Annalisa
collection PubMed
description NR3C1, the gene encoding the glucocorticoid receptor, is polymorphic presenting numerous single nucleotide polymorphisms (SNPs) some of which are emerging as leading cause in the variability of manifestation and/or response to glucocorticoids in human diseases. Since 60–80% of patients with Diamond Blackfan anemia (DBA), an inherited pure red cell aplasia induced by mutations in ribosomal protein genes became transfusion independent upon treatment with glucocorticoids, we investigated whether clinically relevant NR3C1 SNPs are associated with disease manifestation in DBA. The eight SNPs rs10482605, rs10482616, rs7701443, rs6189/rs6190, rs860457, rs6198, rs6196, and rs33388/rs33389 were investigated in a cohort of 91 European DBA patients. Results were compared with those observed in healthy volunteers (n=37) or present in public genome databases of Italian and European populations. Although, cases vs. control analyses suggest that the frequency of some of the minor alleles is significantly altered in DBA patients with respect to healthy controls or to the Italian or other European registries, lack of consistency among the associations across different sets suggests that overall the frequency of these SNPs in DBA is not different from that of the general population. Demographic data (47 females and 31 males) and driver mutations (44 S and 29 L genes and eight no-known mutation) are known for 81 patients while glucocorticoid response is known, respectively, for 81 (36 responsive and 45 non-responsive) and age of disease onsets for 79 (55 before and 24 after 4months of age) patients. Neither gender nor leading mutations were associated with the minor alleles or with disease manifestation. In addition, none of the SNPs met the threshold in the response vs. non-responsive groups. However, two SNPs (rs6196 and rs860457) were enriched in patients manifesting the disease before 4months of age. Although the exact biomechanistical consequences of these SNPs are unknown, the fact that their configuration is consistent with that of regulatory regions suggests that they regulate changes in glucocorticoid response during ontogeny. This hypothesis was supported by phosphoproteomic profiling of erythroid cells expanded ex vivo indicating that glucocorticoids activate a ribosomal signature in cells from cord blood but not in those from adult blood, possibly providing a compensatory mechanism to the driving mutations observed in DBA before birth.
format Online
Article
Text
id pubmed-8549833
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85498332021-10-28 The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis Lonetti, Annalisa Indio, Valentina Dianzani, Irma Ramenghi, Ugo Da Costa, Lydie Pospíšilová, Dagmar Migliaccio, Anna Rita Front Physiol Physiology NR3C1, the gene encoding the glucocorticoid receptor, is polymorphic presenting numerous single nucleotide polymorphisms (SNPs) some of which are emerging as leading cause in the variability of manifestation and/or response to glucocorticoids in human diseases. Since 60–80% of patients with Diamond Blackfan anemia (DBA), an inherited pure red cell aplasia induced by mutations in ribosomal protein genes became transfusion independent upon treatment with glucocorticoids, we investigated whether clinically relevant NR3C1 SNPs are associated with disease manifestation in DBA. The eight SNPs rs10482605, rs10482616, rs7701443, rs6189/rs6190, rs860457, rs6198, rs6196, and rs33388/rs33389 were investigated in a cohort of 91 European DBA patients. Results were compared with those observed in healthy volunteers (n=37) or present in public genome databases of Italian and European populations. Although, cases vs. control analyses suggest that the frequency of some of the minor alleles is significantly altered in DBA patients with respect to healthy controls or to the Italian or other European registries, lack of consistency among the associations across different sets suggests that overall the frequency of these SNPs in DBA is not different from that of the general population. Demographic data (47 females and 31 males) and driver mutations (44 S and 29 L genes and eight no-known mutation) are known for 81 patients while glucocorticoid response is known, respectively, for 81 (36 responsive and 45 non-responsive) and age of disease onsets for 79 (55 before and 24 after 4months of age) patients. Neither gender nor leading mutations were associated with the minor alleles or with disease manifestation. In addition, none of the SNPs met the threshold in the response vs. non-responsive groups. However, two SNPs (rs6196 and rs860457) were enriched in patients manifesting the disease before 4months of age. Although the exact biomechanistical consequences of these SNPs are unknown, the fact that their configuration is consistent with that of regulatory regions suggests that they regulate changes in glucocorticoid response during ontogeny. This hypothesis was supported by phosphoproteomic profiling of erythroid cells expanded ex vivo indicating that glucocorticoids activate a ribosomal signature in cells from cord blood but not in those from adult blood, possibly providing a compensatory mechanism to the driving mutations observed in DBA before birth. Frontiers Media S.A. 2021-10-13 /pmc/articles/PMC8549833/ /pubmed/34721069 http://dx.doi.org/10.3389/fphys.2021.745032 Text en Copyright © 2021 Lonetti, Indio, Dianzani, Ramenghi, Da Costa, Pospíšilová and Migliaccio. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Lonetti, Annalisa
Indio, Valentina
Dianzani, Irma
Ramenghi, Ugo
Da Costa, Lydie
Pospíšilová, Dagmar
Migliaccio, Anna Rita
The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis
title The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis
title_full The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis
title_fullStr The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis
title_full_unstemmed The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis
title_short The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis
title_sort glucocorticoid receptor polymorphism landscape in patients with diamond blackfan anemia reveals an association between two clinically relevant single nucleotide polymorphisms and time to diagnosis
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549833/
https://www.ncbi.nlm.nih.gov/pubmed/34721069
http://dx.doi.org/10.3389/fphys.2021.745032
work_keys_str_mv AT lonettiannalisa theglucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT indiovalentina theglucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT dianzaniirma theglucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT ramenghiugo theglucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT dacostalydie theglucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT pospisilovadagmar theglucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT migliaccioannarita theglucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT lonettiannalisa glucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT indiovalentina glucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT dianzaniirma glucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT ramenghiugo glucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT dacostalydie glucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT pospisilovadagmar glucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis
AT migliaccioannarita glucocorticoidreceptorpolymorphismlandscapeinpatientswithdiamondblackfananemiarevealsanassociationbetweentwoclinicallyrelevantsinglenucleotidepolymorphismsandtimetodiagnosis